急性肺损伤治疗的研究进展

    Research Progress in the Treatment of Acute Lung Injury

    • 摘要: 急性肺损伤(acute lung injury,ALI)是临床常见的危重症,其严重阶段即为急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS),死亡率高达30%~50%,严重威胁人们生命健康。即使患者幸存,肺功能被严重损害,生活质量亦被严重影响,给患者、家庭及社会造成较大的经济负担。ALI的病理机制复杂,其有效治疗是医学界一大难题。目前对ALI的治疗策略主要包括呼吸支持治疗、药物治疗、基因治疗、细胞移植等。本文就ALI的治疗研究进展进行简要综述。

       

      Abstract: Acute lung injury(ALI) is a common clinical critical illness. Its exacerbation stage is acute respiratory distress syndrome(ARDS). The mortality rate is as high as 30%-50%, which seriously threatens people's life and health. Even if the patients survive, the function of lung is severely impaired, thus severely affecting the quality of the patients' life and causing a large economic burden on the patient, family and society. The complex pathological mechanisms of ALI make its effective treatment still a tremendous challenge clinically. Presently, the treatment strategies of ALI mainly include respiratory support therapy, drug therapy, gene therapy, cell transplantation and other means. A brief review of the research progress of ALI therapy is presented.

       

    /

    返回文章
    返回